Inhaled corticosteroids: Benefits and risks

Journal of Asthma

Volumn 33, Issue 1, 1996, Pages 5-16

  Robinson, Douglas S ^a   Geddes, Duncan M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE;

ASTHMA; BONE METABOLISM; CATARACT; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; GROWTH RETARDATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MENTAL DISEASE; META ANALYSIS; PURPURA; REVIEW; RISK BENEFIT ANALYSIS; SKIN ATROPHY; SYMPTOM;

EID: 0030028952     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909609077758     Document Type: Review

References (103)

1. National Heart, Lung, and Blood Institute: Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 85:425-534 (1991).
2. British Thoracic Society, British Paediatric Society, Research Unit of the Royal College of Physicians, Kings Fund Centre, National Asthma Campaign, Royal College of General Practitioners, the General Practitioners in Asthma Group, the British Association of Accident and Emergency Medicine, and the British Paediatric Respiratory Group: Guidelines for the management of asthma. Thorax 48:s1-s24 (1993).
3. Harris DM: Clinical pharmacology of beclomethasone dipropionate. In Topical Steroid Treatment for Asthma and Rhinitis (Mygind N, Clark TJH, editors). Balliere Tindall, London, 1980, 34-17.
4. Toogood JH, Frankish CW, Jennings BH, Baskerville JC, Borga O, Lefcoe NM, Johansson SA: A study of the anti-asthma action of inhaled budesonide. J Allergy Clin Immunol 85:872-80 (1990).
5. Miesfeld RL: Molecular genetics of corticosteroid action. Am Rev Respir Dis 143 (Suppl):S11-S17 (1990).
6. Barnes PJ, Pedersen S: Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 148: (Suppl):S1-S26 (1993).
7. Robinson DS, Hamid Q, Sun Ying, Bentley AM, Assoufi B, North J, Qiu Meng, Durham SR, Kay AB: Prednisolone treatment of asthma is associated with modulation of bronchoalveolar cell interleukin-4, interleukin 5, and interferon gamma cytokine gene expression. Am Rev Respir Dis 148:401-406 (1993).
8. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST: Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145:669-674 (1992).
9. Brogden RN, McTavish D: Budesonide: An update review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis. Drugs 44:375-407 (1992).
10. Ryrfeldt A, Andersson P, Edsbacker S, Tonnesson M, Davies D, Pauwels R: Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur Respir J 63(Suppl 122):86-95 (1982).
11. Johansson SA, Andersson KA, Brattsand R, Gruvstad E, Hedner P: Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur Respir J 63 (Suppl 122):74-82 (1982).
12. Andersson N, Klint S, Randwall G, Wiren JE: Equipotency of budesonide and fluticasone propionate in the vasoconstrictor assay. Clin Exp Allergy, (abstract) 24:182 (1994).
13. Wyrtheim G, Rohdenwald P: Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monophosphate. Biopharm Drug Dispos 11:381-394 (1990).
14. Barnes NC, Marone G, DiMaria GU, Visser S, Utama I, Payne SL: A comparison of fluticasone propionate, 1 mg daily with beclomethasone dipropionate 2 mg daily in the treatment of severe asthma. Eur Respir J 6:877-884 (1993).
15. Lundback B: Evaluation of fluticasone propionate (500 mcg/day) administered either as dry powder via diskhaler or pressurised inhaler. Respir Med 87: 609-620 (1993).
16. Andersson P, Ryrfeldt A: Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17α21-dipropionate in human liver and lung homogenate. J Pharm Pharmacol 36:763-765 (1984).
17. Chaplin MD, Rooks W, Svenson EW, Couper WC, Nerenberg C, Chu NI: Flunisolide metabolism and dynamic of a metabolite. Clin Pharmacol Ther 27:402-413 (1980).
18. Phillipps GH: Structure-activity relationships of topically active steroids: The selection of fluticasone propionate. Respir Med 84(Suppl):A19-23 (1990).
19. Newman SP, Pavia D, Garland N, Clarke SW: Effects of various inhalation modes on the disposition of radioactive pressurised aerosol. Eur J Respir Dis 63 (Suppl 119):57-65 (1982).
20. Svedmyr N, Lofdahl CG, Svedmyr K: The effect of powder aerosol compared to pressurised aerosol. Eur J Respir Dis 63(Suppl 119):81-88 (1982).
21. Brompton Hospital and Medical Research Council: Double blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in chronic bronchial asthma. J Dis Chest 73:121-132 (1979).
22. Smith MJ, Hodson ME: High dose beclomethasone inhaler in the treatment of asthma. Lancet 1:265-268 (1983).
23. Toogood JH, Lefcoe NM, Haines DSMA: A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 59:298-305 (1977).
24. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson SA: Equivalent doses of budesonide and prednisolone in moderate and severe asthma. J Allergy Clin Immunol 84:688-700 (1989).
25. Otulana BA, Varma N, Bullock A, Higgenbottam T: High dose nebulised steroid in the treatment of chronic steroid-dependent asthma. Respir Med 86: 105-108 (1992).
26. Juniper EF, Kline PA, van Zielesheim MA, Ramsdale EH, O'Byrne PM, Hargreave FE: Long term effects of budesonide on airway responsiveness and clinical asthma in inhaled steroid-dependent asthma. Eur Respir J 3:1122-1127 (1990).
27. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, Sovijarvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA: Comparison of a beta agonist terbutaline with an inhaled steroid in newly detected asthma. N Engl J Med 325:388-392 (1988).
28. van Essen-Zandvliet EE, Hughes MD, Waalkens KJ, Duiveman EJ, Pocock SJ, Kerrebjin KF: Effects of 22 months of treatment with inhaled corticosteroids and/or beta agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 146:547-554 (1992).
29. Pedersen S, Ramsgaard O: Budesonide treatment of children with asthma: A dose-response study. Eur Respir 6(Suppl 17):358S (1993).
30. Hummel S, Lehtonen L: Comparison of oral steroid sparing by high dose and low dose inhaled steroid in maintenance treatment of severe asthma. Lancet 340:1483-1487 (1992).
31. Dahl R, Lundbeck B, Malo J-L, Mazza J, Nieminen MM, Saarelainen P, Barnacle H: A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 104:1352-1358 (1993).
32. Greening AP, Ind PW: Addition of salmeterol 50 micrograms BD compared with increasing inhaled corticosteroids in adult asthmatics symptomatic on 200 micrograms BD inhaled steroids. Am J Respir Crit Care Med 149:A208 (1994). (abstract)
33. Woolcock A, Lundback B, Ringdal OLN, Jaques LA: Comparison of the effect of addition of salmeterol with doubling the inhaled steroid dose in asthmatic patients. Am J Respir Crit Care Med 149:A280 (1994) (abstract).
34. Pedersen A, Agertoft L: Effect of long term budesonide treatment on growth, weight, and lung function in children with asthma. Am Rev Respir Dis 147:A265 (1993) (abstract).
35. Juniper EF, Kline PA, Vanzielegmen MA, Hargreave FE: Reduction of budesonide after one year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 87:483-489 (1991).
36. Ernst P, Spitzer WD, Suissa S, Cockcroft D, Habbick B, Horwitz RI, Boivin JF, McNutt M, Buist AS: Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 5:945-952 (1992).
37. Stiksa G, Glenow C, Johanesson N: An open crossover trial with budesonide and beclomethasone dipropionate in patients with bronchial asthma. Eur J Respir Dis 63(Suppl 122):266-267 (1982).
38. Willey RF, Godden DJ, Carmichael J: Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma. Br J Dis Chest 76:61-68 (1982).
39. Rafferty P, Tucker LG, Frame MH: Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: Assessment of relative prednisolone sparing effects. Br J Dis Chest 79:244-250 (1985).
40. Ebden P, Jenkins A, Houston G: Comparison of two high dose corticosteroid aerosol treatments: Beclomethasone dipropionate (1500 μg/day) and budesonide (1600 μg/day) for chronic asthma. Thorax 41: 869-874 (1986).
41. Boe J, Rosenhall L, Alton M: Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy 44:349-355 (1989).
42. Kjellman M, Moller C, Glenow C: A comparison of becotide and budesonide in children. Eur J Respir Dis 63(Suppl 124):127 (1982).
43. Baran D: A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma. Br J Dis Chest 81:170-175 (1987).
44. Springer C, Avital A, Maayan CH: Comparison of budesonide and beclomethasone dipropionate for treatment of asthma. Arch Dis Child 62:815-819 (1987).
45. Field HV, Jenkinson PMA, Frame MH: Asthma treatment with a new corticosteroid budesonide administered twice daily by spacer inhaler. Arch Dis Child 57:864-866 (1982).
46. Keelan P, Frame M, Gray P: Comparison of a new corticosteroid aerosol budesonide in the treatment of chronic asthma. Irish Med J 77:244-247 (1984).
47. Mackenzie CA, Weinberg EG, Tabachnik E, Taylor M, Havnen J, Crescenzi K: A placebo controlled trial of fluticasone propionate in asthmatic children. Eur J Paeditr 152:856-860 (1993).
48. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E: Comparison of the efficacy and safety of inhaled fluticasone propionate 200 μg/day with inhaled beclomethasone dipropionate 400 μg/ day in mild and moderate asthma. Arch Dis Child 69:206-211 (1993).
49. Fabbri L, Burge PS, Croonenburgh L, Warlies F, Wecke B, Ciaccia A, Parker C: Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 48:817-823 (1993).
50. Langdon CG, Thompson J: Fluticasone propionate: A comparison with budesonide in adult asthmatic patients. Eur Respir J 5(Suppl 15):368 (1992) (abstract).
51. Agertoft L, Pedersen S: Importance of the inhalation device on the effect of budesonide. Arch Dis Child 69:130-133 (1993).
52. Brown PH, Matusiewicz SP, Shearing C, Tibi L, Greening AP, Crompton GK: Systemic effects of high dose inhaled steroids: Comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax 48:967-973 (1993).
53. Kruszynska YT, Grennstone M, Home PD: Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax 42:881-884 (1987).
54. Turpeinen M, Sorva R, Juntunen-Backman K: Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. J Allergy Clin Immunol 88:384-389 (1991).
55. Kiviranta K, Turpeinen M: Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma. Thorax 48:974-978 (1993).
56. Johansson SA, Andersson KE, Brattsand R, Gruvstad E, Hedner P: Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol 22:523-529 (1982).
57. Pedersen S, Fuglsang G: Urine cortisol excretion in children treated with high dose inhaled corticosteroids: A comparison of budesonide and beclomethasone. Eur Respir J 1:433-435 (1988).
58. Bisgaard H, Nielsen MD, Andersen S: Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol 81:1088-1095 (1988).
59. Selroos O, Halme M: Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax 46:891-894 (1991).
60. Pedersen S, Steffensen G, Ohlsson SV: The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler. Br J Clin Pharmacol 36:211-214 (1993).
61. Brown PH, Blundell G, Greening AP, Crompton GK: Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med 85:511-516 (1991).
62. Smith R Bone physiology and the osteoporotic process. Respir Dis 87(Suppl A):3-7 (1993).
63. Hosking DJ: Effects of corticosteroids on bone turnover. Respir Dis 87(Suppl A):15-21 (1993).
64. Adinoff AD, Hollister JR: Steroid induced fractures and bone loss in patients with asthma. N Engl J Med 309:265-268 (1983).
65. Ali NJ, Capewel S, Ward MJ: Bone turnover during high dose inhaled corticosteroid therapy. Thorax 46: 160-164 (1991).
66. Jennings B, Andersson K, Johansson SA: Assessment of systemic effects of inhaled glucocorticoids: Comparison of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 40:77-82 (1991).
67. Meeran K, Hattersly A, Burrin J: Oral and inhaled corticosteroids suppress bone formation. Am Rev Respir Dis 143:A625 (1991) (abstract).
68. Peretz A, Bourboux P: Inhaled corticosteroids, bone formation and osteocalcin. Lancet 338:1340 (1991).
69. Pouw EP, Prummel MF, Osting H, Roos CM, Endert E: Beclomethasone inhalation decreases serum osteocalcin concentrations. Br Med J 302:627-628 (1991).
70. Teelucksingh S, Padfield PL, Tibi L, Gough KJ, Holt PR: Inhaled corticosteroids, bone formation and osteocalcin. Lancet 338:60-61 (1991).
71. Toogood JH, Crilly RG, Jones G, Nadean J, Wells GA: Effect of high dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis 136:57-61 (1988).
72. Konig P, Cervantes C, Hillman L: Bone mineralisationin asthmatic children treated with inhaled beclomethasone. J Allergy Clin Immunol 78:312 (1991) (abstract).
73. Luengo M, Delrio L, Guanabens N: Long term effect of oral and inhaled glucocorticoids on bone mass in chronic asthma: A two year follow up study. Eur Respir J 4(Suppl 14):342S (1991).
74. Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM: Bone density in asthmatics taking high dose inhaled beclomethasone dipropionate. Thorax 47:415-418 (1992).
75. Puolijoki H, Liippo K, Herrala J: Does high dose inhaled beclomethasone affect calcium metabolism? Eur Respir J 4(Suppl 14):483S (1991).
76. Reid DM, Nicholl J, Smith MA, Higgins B, Tothill P, Nuki G: Corticosteroids and bone mass in asthma: Comparisons with rheumatoid arthritis. Br Med J 293:1463-1466 (1986).
77. Stead RJ, Horsman A, Cooke NJ, Belchetz P: Bone mineral density in women taking inhaled corticosteroids. Thorax 45:792 (1990) (abstract).
78. Wolff A, Adelsberg B, Aloia J: Effect of inhaled corticosteroid on bone density in asthmatic patients: A pilot study. Ann Allergy 67:117-121 (1991).
79. Agertoft L, Pedersen S: Bone densitometry in children treated for 3-6 years with high dose inhaled budesonide. Eur Respir J 6(Suppl 17):261S (1993) (abstract).
80. Zeitlin SR, Crowley S, Hindmarsh PC, Brook CGD: Inhaled corticosteroids and growth. Eur Respir Rev 3(13):333-337 (1993).
81. Warner JO: Use of corticosteroids in children with asthma. Eur Respir Rev 3(13):326-328 (1993).
82. Wolthers OD, Pedersen S: Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 68:673-676 (1993).
83. Capewell S, Reynolds S, Shuttleworth D, Edwards C, Finlay AY: Purpura and dermal thinning associated with high dose inhaled corticosteroids. Br Med J 300: 1548-1551 (1990).
84. Mak VHF, Melchor R, Spiro S: Easy bruising as a side-effect of inhaled corticosteroids. Eur Respir J 5:1068-1074 (1992).
85. Allen MB, Ray SG, Leitch AG, Dhillon B, Cullen B: Steroid aerosols and cataract formation. Br Med J 229:432-433 (1989).
86. Kewley GD: Possible association between beclomethasone dipropionate aerosol and cataract formation. Aust Paediatr J 16:117-118 (1980).
87. Toogood JH, Markov AE, Baskerville J, Dyson C: Association of ocular cataracts with inhaled and oral steroid therapy during long term treatment for asthma. J Allergy Clin Immunol 91:571-579 (1993).
88. Fraundfelder FT, Meyer SM: Posterior subcapsular cataracts associated with nasal or inhalational corticosteroids. Am J Ophthalmol 109:489-490 (1990).
89. Rooklin AR, Lamprt SI, Jaeger EA, McGeady S, Mansman HC: Posterior subcapsular cataracts in steroid-requiring asthmatic children. J Allergy Clin Immunol 63:383-386 (1979).
90. Mitchell DM, Collins JV: Do corticosteroids really alter mood? Postgrad Med J 60:467-470 (1984).
91. Simons FER, Persaud MP, Gillespie CA, Cheang M, Shuckett EP: Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet 342:776-778 (1993).
92. Goldstein ET, Preskom SH: Mania triggered by a steroid nasal spray in a patient with stable bipolar disorder. Am J Psychiatry 146:1076-1077 (1989).
93. Meysboom RHB: Budesonide and psychic side effects. Ann Intern Med 109:683 (1988).
94. Connett G, Lenney W: Inhaled budesonide and behavioural disturbances. Lancet 338:634 (1991).
95. Lewis LD, Cochrane GM: Psychosis in a child inhaling budesonide. Lancet 2:634 (1983).
96. Willey RF, Milner JR, Crompton GK, Grant IWB: Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest 70:32-38 (1976).
97. Shaw NJ, Edmunds AT: Inhaled beclomethasone and oral candidiasis. Arch Dis Child 61:788-790 (1986).
98. Skinner C, Williams AJ: Dysphonia caused by inhaled steroids: Recognition of a characteristic laryngeal abnormality. Thorax 39:686 (1984).
99. Gaddie J, Petrie GR, Reid IW, Sinclair DJM, Skinner C, Palmer KNV: Aerosol beclomethasone dipropionate: A dose response study in chronic bronchial asthma. Lancet 2:280 (1973).
100. Costello JF, Clark TJH: Response of patients receiving high dose beclomethasone dipropionate. Thorax 29:571-573 (1974).
101. Boe J, Rosenhall L, Alton M, Carlsson LG, Carlsson U, Hermansson BA: Comparison of dose response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy 44:349-355 (1989).
102. Bjorkander J, Formgren H, Johansson SA, Millqvist E: Methodological aspects of clinical trials with inhaled corticosteroids: Results of two comparisons between two steroid aerosols in patients with asthma. Eur J Respir Dis 63(Suppl 122):108-117 (1982).
103. Johansson SA, Dahl R: A double blind dose response study of budesonide by inhalation in patients with bronchial asthma. Allergy 43:173-178 (1988).